By Alec Mattinson2022-09-24T11:23:00
Former GSK consumer arm Haleon posted strong double-digit growth in its first financial results as a listed company, although investors were more interested in its tough stance against its former parent over Zantac litigation.
Already have an account? Sign in here
Already have an account? Sign in here